Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.46 USD | +0.79% | +4.99% | -14.43% |
Sales 2024 * | 230M 287M 392M | Sales 2025 * | 244M 305M 417M | Capitalization | 2.37B 2.96B 4.05B |
---|---|---|---|---|---|
Net income 2024 * | -71M -88.69M -121M | Net income 2025 * | -90M -112M -154M | EV / Sales 2024 * | 9.04 x |
Net cash position 2024 * | 293M 366M 500M | Net cash position 2025 * | 219M 274M 374M | EV / Sales 2025 * | 8.81 x |
P/E ratio 2024 * |
-37.7
x | P/E ratio 2025 * |
-26.7
x | Employees | 497 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.6% |
Latest transcript on Immunocore Holdings plc
1 day | +0.79% | ||
1 week | +4.99% | ||
Current month | -10.06% | ||
1 month | -8.05% | ||
3 months | -16.46% | ||
6 months | +36.43% | ||
Current year | -14.43% |
Managers | Title | Age | Since |
---|---|---|---|
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Brian DiDonato
DFI | Director of Finance/CFO | 57 | 20-03-31 |
John Trainer
COO | Chief Operating Officer | 50 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Perez
BRD | Director/Board Member | 59 | 19-08-31 |
John Bell
CHM | Chairman | 71 | 15-02-28 |
Bahija Jallal
CEO | Chief Executive Officer | 62 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 1,026 M€ | +6.95% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.14% | 5 M€ | +8.63% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 58.46 | +0.79% | 403,551 |
24-04-25 | 58 | -0.80% | 496,622 |
24-04-24 | 58.47 | +2.02% | 394,870 |
24-04-23 | 57.31 | +2.67% | 302,166 |
24-04-22 | 55.82 | +0.25% | 295,838 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.43% | 2.95B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- IMCR Stock